Why older Americans are quitting weight-loss drugs in droves
Studies show that older patients discontinue using GLP-1s at higher rates.
From The Times
December 29, 2025

People over 65 are often prime targets for GLP-1 weight-loss drugs like Ozempic, doctors say. But two studies have shown that older patients stop using them at higher rates.

An artist’s image of a person with a bowed head against a backdrop of floating pill bottles and money.

Dóra Kisteleki

Here’s what’s going on. →

MORE FROM WELL

A group of silhouetted people making a toast with alcoholic drinks at a bar filled with red light.

This drinking habit is more dangerous than bingeing. →

A man runs beside a striped brick wall in orange shorts and a blue top.

Running and walking are both good for you. But one is better. →

A block of tofu sitting on a jar of dry oats and a dried bean pod sitting on the top of a cut eggplant.

This little-known diet can actually lower your cholesterol. →

Essential news and guidance to live your healthiest life. Plus, our 5-Day Brain Health Challenge starts Jan. 5.

Sign up for the Well newsletter.

Essential news and guidance to live your healthiest life. Plus, our 5-Day Brain Health Challenge starts Jan. 5.

Get it in your inbox

If you received this newsletter from someone else, subscribe here.

Need help? Review our newsletter help page or contact us for assistance.

You received this message because you signed up for updates from The New York Times.

To stop receiving From The Times, unsubscribe. To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings.

Subscribe to The Times

Connect with us on:

facebookxinstagramwhatsapp

Change Your EmailPrivacy PolicyContact UsCalifornia Notices

LiveIntent LogoAdChoices Logo

The New York Times Company. 620 Eighth Avenue New York, NY 10018